[ Price : $8.95]
FDA says the Oncology Center of Excellences Project Orbis received 60 applications in its first full year of existence and approve...[ Price : $8.95]
FDA grants Turning Point Therapeutics a breakthrough therapy designation for repotrectinib and its use in treating certain patient...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include Natures Boost and Valentus.[ Price : $8.95]
President-elect Joe Biden names California attorney general Xavier Becerra as his nominee for HHS secretary, a sign that an FDA co...[ Price : $8.95]
Federal Register notice: FDA announces that Y-mAbs Therapeutics was awarded a priority review voucher related to the approval of D...[ Price : $8.95]
FDA tests its capability to receive annotated electrocardiogram waveform data in electronic format under the Health Level Seven (H...[ Price : $8.95]
Former FDA Office of Compliance and Biologics Quality deputy director Mark I. Schwartz criticizes FDA for its slow response to the...[ Price : $8.95]
The Justice Department files a civil complaint to stop AMARC Enterprises from distributing unapproved and misbranded drugs and adu...